Literature DB >> 16809286

Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo.

Jason M Brenchley1, Laura E Ruff, Joseph P Casazza, Richard A Koup, David A Price, Daniel C Douek.   

Abstract

CD4(+) T-cell help is essential for effective immune responses to viruses. In human immunodeficiency virus (HIV) infection, CD4(+) T cells specific for HIV are infected by the virus at higher frequencies than other memory CD4(+) T cells. Here, we demonstrate that HIV-specific CD4(+) T cells are barely detectable in most infected individuals and that the corresponding CD4(+) T cells exhibit an immature phenotype compared to both cytomegalovirus (CMV)-specific CD4(+) T cells and other memory CD4(+) T cells. However, in two individuals, we observed a rare and diametrically opposed pattern in which HIV-specific CD4(+) T-cell populations of large magnitude exhibited a terminally differentiated immunophenotype; these cells were not preferentially infected in vivo. Clonotypic analysis revealed that the HIV-specific CD4(+) T cells from these individuals were cross-reactive with CMV. Thus, preferential infection can be circumvented in the presence of cross-reactive CD4(+) T cells driven to maturity by coinfecting viral antigens, and this physical proximity rather than activation status per se is an important determinant of preferential infection based on antigen specificity. These data demonstrate that preferential infection reduces the life span of HIV-specific CD4(+) T cells in vivo and thereby compromises the generation of effective immune responses to the virus itself; further, this central feature in the pathophysiology of HIV infection can be influenced by the cross-reactivity of responding CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809286      PMCID: PMC1489023          DOI: 10.1128/JVI.00070-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape.

Authors:  Daniel C Douek; Michael R Betts; Jason M Brenchley; Brenna J Hill; David R Ambrozak; Ka-Leung Ngai; Nitin J Karandikar; Joseph P Casazza; Richard A Koup
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

2.  CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?

Authors:  Zvi Grossman; Martin Meier-Schellersheim; Ana E Sousa; Rui M M Victorino; William E Paul
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

Review 3.  T cell dynamics in HIV-1 infection.

Authors:  Daniel C Douek; Louis J Picker; Richard A Koup
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 4.  Similarities and differences in CD4+ and CD8+ effector and memory T cell generation.

Authors:  Robert A Seder; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-09       Impact factor: 25.606

5.  Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells.

Authors:  Jason M Brenchley; Nitin J Karandikar; Michael R Betts; David R Ambrozak; Brenna J Hill; Laura E Crotty; Joseph P Casazza; Janaki Kuruppu; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

6.  Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.

Authors:  David A Price; George Scullard; Annette Oxenius; Ruth Braganza; Simon A Beddows; Shamim Kazmi; John R Clarke; Gabriele E Johnson; Jonathan N Weber; Rodney E Phillips
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo.

Authors:  Chang-You Wu; Joanna R Kirman; Masashi J Rotte; Dylan F Davey; Steve P Perfetto; Elizabeth G Rhee; Brenda L Freidag; Brenna J Hill; Daniel C Douek; Robert A Seder
Journal:  Nat Immunol       Date:  2002-08-12       Impact factor: 25.606

8.  Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection.

Authors:  Alexandre Harari; G Paolo Rizzardi; Kim Ellefsen; Donatella Ciuffreda; Patrick Champagne; Pierre-Alexandre Bart; Daniel Kaufmann; Amalio Telenti; Roland Sahli; Giuseppe Tambussi; Laurent Kaiser; Adriano Lazzarin; Luc Perrin; Giuseppe Pantaleo
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

9.  Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection.

Authors:  Mark J Boaz; Anele Waters; Shahed Murad; Philippa J Easterbrook; Annapurna Vyakarnam
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

10.  In patients on prolonged HAART, a significant pool of HIV infected CD4 T cells are HIV-specific.

Authors:  Audrey Demoustier; Brigitte Gubler; Olivier Lambotte; Marie-Ghislaine de Goër; Christine Wallon; Cécile Goujard; Jean-François Delfraissy; Yassine Taoufik
Journal:  AIDS       Date:  2002-09-06       Impact factor: 4.177

View more
  49 in total

1.  Modelling deuterium labelling of lymphocytes with temporal and/or kinetic heterogeneity.

Authors:  Rob J De Boer; Alan S Perelson; Ruy M Ribeiro
Journal:  J R Soc Interface       Date:  2012-04-18       Impact factor: 4.118

2.  DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cells.

Authors:  Lara Vojnov; Alexander T Bean; Eric J Peterson; Maria J Chiuchiolo; Jonah B Sacha; Ferencz S Denes; Matyas Sandor; Deborah H Fuller; James T Fuller; Christopher L Parks; Adrian B McDermott; Nancy A Wilson; David I Watkins
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

3.  Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection.

Authors:  Gurvinder Kaur; Michael Tuen; Diana Virland; Sandra Cohen; Narinder K Mehra; Christian Münz; Sayed Abdelwahab; Alfredo Garzino-Demo; Catarina E Hioe
Journal:  Virology       Date:  2007-09-04       Impact factor: 3.616

4.  CD4+ memory stem cells are infected by HIV-1 in a manner regulated in part by SAMHD1 expression.

Authors:  Caroline O Tabler; Mark B Lucera; Aiman A Haqqani; David J McDonald; Stephen A Migueles; Mark Connors; John C Tilton
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

5.  The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers.

Authors:  Juan P Giraldo-Vela; Richard Rudersdorf; Chungwon Chung; Ying Qi; Lyle T Wallace; Benjamin Bimber; Gretta J Borchardt; Debra L Fisk; Chrystal E Glidden; John T Loffredo; Shari M Piaskowski; Jessica R Furlott; Juan P Morales-Martinez; Nancy A Wilson; William M Rehrauer; Jeffrey D Lifson; Mary Carrington; David I Watkins
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

6.  Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.

Authors:  Jason M Brenchley; Mirko Paiardini; Kenneth S Knox; Ava I Asher; Barbara Cervasi; Tedi E Asher; Phillip Scheinberg; David A Price; Chadi A Hage; Lisa M Kholi; Alexander Khoruts; Ian Frank; James Else; Timothy Schacker; Guido Silvestri; Daniel C Douek
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

7.  Design and preclinical development of a recombinant protein and DNA plasmid mixed format vaccine to deliver HIV-derived T-lymphocyte epitopes.

Authors:  Leslie E Walker; Lo Vang; Xuefei Shen; Brian D Livingston; Penny Post; Alessandro Sette; C Steven Godin; Mark J Newman
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

8.  Autocrine production of beta-chemokines protects CMV-Specific CD4 T cells from HIV infection.

Authors:  Joseph P Casazza; Jason M Brenchley; Brenna J Hill; Ribka Ayana; David Ambrozak; Mario Roederer; Daniel C Douek; Michael R Betts; Richard A Koup
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

9.  CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals.

Authors:  Alessandra Bandera; Giulio Ferrario; Marina Saresella; Ivana Marventano; Alessandro Soria; Fabio Zanini; Francesca Sabbatini; Monica Airoldi; Giulia Marchetti; Fabio Franzetti; Daria Trabattoni; Mario Clerici; Andrea Gori
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

10.  CpG methylation controls reactivation of HIV from latency.

Authors:  Jana Blazkova; Katerina Trejbalova; Françoise Gondois-Rey; Philippe Halfon; Patrick Philibert; Allan Guiguen; Eric Verdin; Daniel Olive; Carine Van Lint; Jiri Hejnar; Ivan Hirsch
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.